
Athira Pharma, Inc.
Athira Pharma, Inc. (ATHA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
atha · stock forecast · 5 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Hold
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$33.00
Consensus
$13.33
+178.3% upside
Low
$3.00
Median: $4 · Last Close: $4.79
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$13.33
178.3% upside
High Target
$33
588.9%
Low Target
$3
-37.4%
Current Price
$4.79
as of today
Based on analyst price targets, the ATHA stock price prediction for the next 12 months ranges from $3 to $33. The consensus ATHA price forecast of $13.33 implies 178.3% upside from the current price of $4.79.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.55 | ↓ 5.00% |
1-day model range: $4.46–$4.64. Peak: $4.64 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ATHA · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-09-19 | Mizuho | Downgrade ↓ | Outperform→Neutral |
| 2024-09-04 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2024-09-04 | BTIG | Downgrade ↓ | Buy→Neutral |
| 2024-06-20 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-05-16 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-08-11 | JMP Securities | Maintains | Outperform→Outperform |
| 2023-05-15 | Mizuho | Maintains | Buy→Buy |
| 2023-03-30 | BTIG | Maintains | Buy→Buy |
| 2022-06-23 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2022-06-23 | Stifel | Downgrade ↓ | Buy→Hold |
Wall Street analysts have recently issued updated ratings on Athira Pharma, Inc. (ATHA) stock. Of the recent 11 rating actions, 0 were upgrades and 6 were downgrades. 5 analysts currently cover ATHA.
Analyst Recommendation Trends
ATHA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
Revenue Next Year
$13M
EPS This Year
$-6.24
EPS Next Year
$-4.87
↓ 22.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ATHA EPS of $-6.24 for the current fiscal year, based on estimates from 1 analysts. The ATHA revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ATHA stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ATHA price target is $13.33 (+178.3% upside), with an analyst consensus of Hold.
The ATHA short-term stock prediction for tomorrow is $4.55 (-5.00%).
Athira Pharma, Inc. trades on NASDAQ under the ticker ATHA. The ATHA stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.
Frequently asked questions
ATHA forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month ATHA price target is $13.33, with a high forecast of $33.00 and a low of $3.00. The median price target is shown in the chart above when available. This implies +178.3% potential upside from the current price of $4.79.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.